title: Ablative therapy for liver tumours.
abstract: Established ablative therapies for the treatment of primary and secondary liver tumours, including percutaneous ethanol injection, cryotherapy, and radiofrequency ablation, are discussed. Newer techniques such as magnetic resonance imaging guided laser interstitial thermal therapy of liver tumours has produced a median survival rate of 40.8 months after treatment. The merits of this newly emerging technique are discussed, together with future developments, such as focused ultrasound therapy, which holds the promise of non-invasive thermoablation treatment on an outpatient basis.
authors.affiliation: Department of Interventional Magnetic Resonance Imaging, Imperial College School of Medicine, St Mary's Hospital, London, UK.
authors.forename: E A
authors.initials: EA
authors.lastname: Dick
authors.forename: S D
authors.initials: SD
authors.lastname: Taylor-Robinson
authors.forename: H C
authors.initials: HC
authors.lastname: Thomas
authors.forename: W M W
authors.initials: WM
authors.lastname: Gedroyc
mesh_terms: D017115:Catheter Ablation / Q000379:methods; D003452:Cryosurgery / Q000379:methods; D006801:Humans; D006979:Hyperthermia, Induced / Q000379:methods; D053685:Laser Therapy; D008113:Liver Neoplasms / Q000556:secondary / Q000601:surgery / Q000628:therapy*; D016031:Liver Transplantation; D008279:Magnetic Resonance Imaging; D015642:Radiology, Interventional